VIR logo

VIR
Vir Biotechnology Inc

6,852
Mkt Cap
$1.43B
Volume
211.00
52W High
$10.94
52W Low
$4.16
PE Ratio
-2.83
VIR Fundamentals
Price
$8.96
Prev Close
$8.99
Open
$8.90
50D MA
$8.25
Beta
1.61
Avg. Volume
5.71M
EPS (Annual)
-$3.16
P/B
1.63
Rev/Employee
$186,801.09
$464.19
Loading...
Loading...
News
all
press releases
Vir Biotechnology (NASDAQ:VIR) CAO Brent Sabatini Sells 7,711 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CAO Brent Sabatini sold 7,711 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Vir Biotechnology (NASDAQ:VIR) CAO Sells $70,324.32 in Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CAO Brent Sabatini sold 7,711 shares of Vir Biotechnology stock in a transaction dated Monday, March 23rd. The shares were sold at an average...
MarketBeat·2d ago
News Placeholder
Hudson Bay Capital Management LP Grows Position in Vir Biotechnology, Inc. $VIR
Hudson Bay Capital Management LP increased its holdings in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 31.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 911,882 shares of the company's stock after purc...
MarketBeat·6d ago
News Placeholder
Vanguard Group Inc. Lowers Stock Position in Vir Biotechnology, Inc. $VIR
Vanguard Group Inc. cut its stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·20d ago
News Placeholder
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...
PR Newswire·22d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Stock Price Expected to Rise, HC Wainwright Analyst Says
HC Wainwright raised their price target on Vir Biotechnology from $15.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat·23d ago
News Placeholder
Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $9.51...
MarketBeat·23d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price...
MarketBeat·24d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised Vir Biotechnology from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·27d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 3,117 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) EVP Verneuil Vanina De sold 3,117 shares of Vir Biotechnology stock in a transaction on Tuesday, February 24th. The shares were sold at an...
MarketBeat·28d ago
<
1
2
...
>

Latest VIR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.